SummaryWHO has fully prequalified two COVID-19 rapid antigen tests—SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term quality, safety and accuracy, enabling bulk procurement and wider access. With COVID-19 still circulating, these tests remain crucial, especially in low-income countries with limited testing.